Earnings Results: Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations.
Computers Tech Games Crypto Music and More
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when its revenues moved up 2%. Revenues increased by […]
The post Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report first appeared on AlphaStreet.